Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

SIMPLE SUMMARY: Currently, clinical studies exploring the impact of high body fat on toxicities after receiving immune checkpoint inhibitors (ICIs) among cancer patients are limited. Here, we analyze data from a health care system serving the mid-Atlantic geographic region to assess how body fat can...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongyu, Shah, Neil J., Cook, Michael, Blackburn, Matthew, Serzan, Michael T., Advani, Shailesh, Potosky, Arnold L., Madhavan, Subha, Belouali, Anas, Atkins, Michael B., Braithwaite, Dejana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657283/
https://www.ncbi.nlm.nih.gov/pubmed/34885219
http://dx.doi.org/10.3390/cancers13236109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657283/
https://www.ncbi.nlm.nih.gov/pubmed/34885219
http://dx.doi.org/10.3390/cancers13236109

Ejemplares similares